Clinical Trial Update: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis [Phase 2, Phase 3]

View source ↗

Summary

The document notes the completion of a Phase 2/3 add-on clinical trial evaluating pentoxifylline for cutaneous leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Centro Internacional de Entrenamiento e Investigaciones Médicas | Conditions: Cutaneous Leishmaniasis | Phase 2, Phase 3 | Status: COMPLETED